Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Access to the study page now returns a 403 Forbidden error, displaying a 403 header and a Home link instead of the study details. The previous study content appears to be inaccessible on this page.
    Difference
    22%
    Check dated 2026-09-22T21:00:12.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A new page revision label 'Revision: v3.7.0' is now displayed, indicating an update to the page version. The old revision label 'Revision: v3.6.6' and related topics such as 'Melanoma' and 'MedlinePlus Genetics' were removed.
    Difference
    0.2%
    Check dated 2026-09-15T20:53:04.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The study record adds posted results and a new Phase II description with expanded endpoints and timing for efficacy measurements (e.g., ORR, PFS, PD-1/LAG-3 expression, and tumor assessments).
    Difference
    9%
    Check dated 2026-09-01T17:58:52.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The related topics section now lists Melanoma and MedlinePlus Genetics. This is a navigational/content enhancement that helps users connect the study with its disease context and genetics resources without changing any trial data.
    Difference
    0.2%
    Check dated 2026-08-25T16:37:48.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.6.4 to v3.6.5. This reflects a new version of the page in the revision history.
    Difference
    0.1%
    Check dated 2026-08-11T08:23:00.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 tag has been added. The previous Revision: v3.6.3 tag, along with certain related topics text (Melanoma, MedlinePlus Genetics), was removed.
    Difference
    0.2%
    Check dated 2026-07-28T03:26:16.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.